Screening: CyTOF-the next generation of cell detection

Nature Reviews Rheumatology

Volumn 7, Issue 9, 2011, Pages 502-503

  Cheung, Regina K ^a   Utz, Paul J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BELIMUMAB; CELL SURFACE MARKER; EPITOPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA; RITUXIMAB; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

B LYMPHOCYTE; CYTOMETRY; FELTY SYNDROME; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOPHENOTYPING; PRIORITY JOURNAL; RHEUMATIC DISEASE; SHORT SURVEY; SINGLE CELL MASS CYTOMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOLOGICAL MARKERS; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM; IMMUNOPHENOTYPING; INDIVIDUALIZED MEDICINE; RHEUMATIC DISEASES; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS;

EID: 80052405097     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.110     Document Type: Short Survey

References (9)

1. Bendall, S. C., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
2. Crow, M. K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res. Ther. 12 (Suppl. 1), S5 (2010).
3. Obermoser, G. & Pascual, V. The interferon-α signature of systemic lupus erythematosus. Lupus 19, 1012-1019 (2010).
4. Lande, R., et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011).
5. Balboni, I., et al. Multiplexed protein array platforms for analysis of autoimmune diseases. Annu. Rev. Immunol. 24, 391-418 (2006).
6. Silverman, G. J., et al. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin. Exp. Immunol. 153, 102-116 (2008). (Pubitemid 351809346)
7. Graham, R. R., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38, 550-555 (2006).
8. Bauer, J. W., et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 3, e491 (2006).
9. Bauer, J. W., et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum. 60, 3098-3107 (2009).